Sabine Mueller, Md, Phd
Clinical trials sponsored by Sabine Mueller, Md, Phd, explained in plain language.
-
New hope for young brain tumor patients: experimental drug combo enters trials
Disease control Not yet recruitingThis study tests whether adding an experimental drug (ADI-PEG 20) to standard radiation and chemotherapy can help children, teens, and young adults with newly diagnosed high-grade glioma. About 97 participants will receive the drug combination to see if it is safe and delays tumo…
Phase: PHASE1, PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated May 17, 2026 10:41 UTC
-
New hope for kids with brain cancer: thyroid hormone combo targets relapsed tumors
Disease control Not yet recruitingThis study tests a thyroid hormone (liothyronine, or L-T3) alone or with standard chemotherapy in 69 children and young adults whose medulloblastoma has returned or worsened. The goal is to see if adding L-T3 makes treatment safer and more effective. Participants receive either L…
Phase: PHASE1, PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated May 17, 2026 10:40 UTC
-
Promising new combo therapy targets deadly childhood brain tumor
Disease control Not yet recruitingThis study tests two new drug combinations for children, adolescents, and young adults whose atypical teratoid rhabdoid tumor (ATRT) has come back or is growing despite treatment. About 29 participants will receive either gemcitabine plus paxalisib or another novel therapy. The g…
Phase: PHASE2 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control
Last updated May 14, 2026 12:02 UTC